Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.
about
Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitorsMolecular mechanisms of epithelial-mesenchymal transitionForkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage responseOverexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaThe miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.Nuclear factor I-C (NFIC) regulates dentin sialophosphoprotein (DSPP) and E-cadherin via control of Krüppel-like factor 4 (KLF4) during dentinogenesis.Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.Transcription factors that convert adult cell identity are differentially polycomb repressedInositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancerMolecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatelliteMicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signalingCytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomasIdentical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart diseaseNuclear JAK2: form and function in cancer.JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.MicroRNA-210 is increased and it is required for dedifferentiation of osteosarcoma cell line.Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer.Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype.The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progressionGenomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease.Up-regulation of long non-coding RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to promote metastasis by associating with Snail1 in gastric cancerFoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.Identification of the key transcription factors in esophageal squamous cell carcinoma.Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1
P2860
Q26849792-0FE810A2-029A-40C8-871C-5BEA15322C68Q27013743-F9D3617B-ABB3-44ED-8FB0-27AB01A32A09Q28270475-56D7CD0A-7F37-4A9B-B9C5-EFD3A51C8442Q28273449-12E47ABF-BEAE-457E-BEED-0C06A83E3A4BQ28389376-465CDA1C-B62B-4AD3-97C5-6AC6EBA22BDCQ34317321-73EF2755-EBB3-45AC-A155-96EDB4659166Q34544488-219BB828-1296-4D11-82B9-8BFB10ED9610Q34708573-398295AA-B20F-450F-9058-D8B64A4793D8Q35090038-E15C6249-7B3B-40F7-932F-CC776057FDF9Q35177151-39522751-B724-4695-A948-BA2987229C6DQ35486982-B152AB4A-2746-475A-94D1-853E0774FEAFQ35781465-2665A237-E3B0-4A38-B347-B6E51C6BBC27Q35933347-2E2CC5EE-FF6A-4F44-B297-F306502F55C5Q36581878-6041692A-4275-4A1F-A210-D32216A97809Q37367626-96EA8628-123C-4A14-BB04-550E497553F2Q37910092-530A2763-9580-460F-A541-A763BFDFF515Q37926574-1229C1AA-E5FA-46B1-918F-13A619A4720FQ38723889-7BD45A47-27EC-4DC7-B000-890E6B2E36F6Q39067507-506EEB3D-DCDF-4793-ACF0-3FE07361021EQ39233205-90EB5E4C-898D-437B-B2B5-7E0D541DBD45Q39375100-69A30552-73F7-4711-9C2F-C1867F62C3F1Q39556002-568A783D-57BE-41F9-9027-1495E6626039Q40195531-A77F65DE-8A59-4EEE-B7D6-250FCFC4D872Q41637093-17905B35-C615-4AF4-8789-2A8BC01775EAQ41826361-C7780669-4296-4712-AAB4-83F0C5FF35BFQ42242173-BFDD7ADB-413A-42A6-93C8-A20E6E930FAFQ42329883-DB7491A8-2479-418A-859F-7ACD9973884AQ51337382-7E8C5E09-43EC-4B52-930E-85FE2510B9FAQ52722996-308886A7-DE1A-41B7-8F47-AFFFEF0094D9Q54447837-FF04C903-FCBD-4E3D-8420-2237B1C9738BQ58754959-0302B377-EA0D-411D-8757-BE916B64226C
P2860
Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@en
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@nl
type
label
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@en
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@nl
prefLabel
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@en
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@nl
P2093
P1433
P1476
Nuclear Janus-activated kinase ...... by repressing Forkhead box F1.
@en
P2093
Anikó Kovács
Gunnar Bjursell
Jeanette Nilsson
Khalil Helou
Marie Kannius-Janson
Mårten Fernö
Pär-Ola Bendahl
P304
P356
10.1158/0008-5472.CAN-09-1677
P407
P577
2010-02-09T00:00:00Z